UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000027612
Receipt No. R000031642
Scientific Title A prospective study of preventive effect of tadalafil on urethral stricture after transurethral surgery
Date of disclosure of the study information 2017/06/05
Last modified on 2021/06/06 (Ver. 5)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title A prospective study of preventive effect of tadalafil on urethral stricture after transurethral surgery
Acronym Preventive effect of tadalafil on urethral stricture after transurethral surgery
Scientific Title A prospective study of preventive effect of tadalafil on urethral stricture after transurethral surgery
Scientific Title:Acronym Preventive effect of tadalafil on urethral stricture after transurethral surgery
Region
Japan

Condition
Condition urethral stricture
Classification by specialty
Urology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To examine preventive effect of tadalafil on urethral stricture after transurethral surgery
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1 Confirmatory
Trial characteristics_2 Pragmatic
Developmental phase Phase III

Assessment
Primary outcomes Frequency of urethral stricture
Key secondary outcomes

Base
Study type Interventional

Study design
Basic design Parallel
Randomization Randomized
Randomization unit Individual
Blinding Open -no one is blinded
Control No treatment
Stratification NO
Dynamic allocation NO
Institution consideration Institution is considered as a block.
Blocking YES
Concealment Pseudo-randomization

Intervention
No. of arms 2
Purpose of intervention Prevention
Type of intervention
Medicine
Interventions/Control_1 tadarafil 5mg per day orally
Interventions/Control_2 no medication
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit

Not applicable
Age-upper limit

Not applicable
Gender Male
Key inclusion criteria Male patients receiving transurethral surgery
Key exclusion criteria NO user, allergy to tadalafil and ischemic heart disease
Target sample size 100

Research contact person
Name of lead principal investigator
1st name Hisashi
Middle name
Last name Matsushima
Organization Tokyo Metropolitan Police Hospital
Division name Department of Urology
Zip code 164-0001
Address 4-22-1, Nakano, Nakano-ku, Tokyo, Japan
TEL 03-5343-5611
Email hmatsu53@me.com

Public contact
Name of contact person
1st name Hisashi
Middle name
Last name Matsushima
Organization Tokyo Metropolitan Police Hospital
Division name Department of Urology
Zip code 164-0001
Address 4-22-1, Nakano, Nakano-ku, Tokyo, Japan
TEL 03-5343-5611
Homepage URL http://www.keisatsubyoin.or.jp/research.html
Email yakuzai@keisatsubyoin.or.jp

Sponsor
Institute Hisashi Matsushima
Tokyo Metropolitan Police Hospital
Department of Urology
Institute
Department

Funding Source
Organization Hisashi Matsushima
Tokyo Metropolitan Police Hospital
Department of Urology
Organization
Division
Category of Funding Organization Non profit foundation
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization An Institutional Review Board in TMPH
Address 4-22-1, Nakano, Nakano-ku, Tokyo, Japan
Tel 03-5343-5611
Email yakuzai@keisatsubyoin.or.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2017 Year 06 Month 05 Day

Related information
URL releasing protocol http://www.keisatsubyoin.or.jp/research.html
Publication of results Unpublished

Result
URL related to results and publications http://www.keisatsubyoin.or.jp/research.html
Number of participants that the trial has enrolled 60
Results Under investigation
Results date posted
2021 Year 06 Month 06 Day
Results Delayed
Delay expected
Results Delay Reason Preparing to submit
Date of the first journal publication of results
Baseline Characteristics Patients receiving transurethral surgery for BPH
Participant flow Finished
Adverse events Nothing
Outcome measures Risk factor of urethral stricture
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Completed
Date of protocol fixation
2017 Year 02 Month 08 Day
Date of IRB
2017 Year 02 Month 01 Day
Anticipated trial start date
2017 Year 02 Month 09 Day
Last follow-up date
2019 Year 02 Month 09 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information

Management information
Registered date
2017 Year 06 Month 02 Day
Last modified on
2021 Year 06 Month 06 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000031642